Research ArticleArticle
The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis
Iago Pinal-Fernandez, Livia A. Casciola-Rosen, Lisa Christopher-Stine, Andrea M. Corse and Andrew L. Mammen
The Journal of Rheumatology July 2015, jrheum.141443; DOI: https://doi.org/10.3899/jrheum.141443
Iago Pinal-Fernandez
From the Vall d’Hebron University Hospital, Barcelona, Spain; Johns Hopkins University School of Medicine, Baltimore; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), US National Institutes of Health (NIH), Bethesda, Maryland, USA. The Johns Hopkins Rheumatic Disease Research Core Center, where the autoantibody assays were performed, is supported by NIH grant P30-AR-053503. Ms. Casciola-Rosen is supported by grant R56 AR062615-01A1. Dr. Christopher-Stine’s work was supported by the Huayi and Siuling Zhang Discovery Fund. This research was supported (in part) by the Intramural Research Program of the NIAMS of the NIH. I. Pinal-Fernandez, MD, PhD, Autoimmune Systemic Diseases Unit, Vall d’Hebron University Hospital; L.A. Casciola-Rosen, PhD; L. Christopher-Stine, MD, MPH; A.M. Corse, MD, Johns Hopkins University School of Medicine; A.L. Mammen, NIAMS, NIH. Address correspondence to Dr. A.L. Mammen, Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Expression, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Drive, Room 1146, Building 50, MSC 8024, Bethesda, Maryland 20892, USA. E-mail: andrew.mammen@nih.gov. Accepted for publication April 24, 2015.
Livia A. Casciola-Rosen
From the Vall d’Hebron University Hospital, Barcelona, Spain; Johns Hopkins University School of Medicine, Baltimore; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), US National Institutes of Health (NIH), Bethesda, Maryland, USA. The Johns Hopkins Rheumatic Disease Research Core Center, where the autoantibody assays were performed, is supported by NIH grant P30-AR-053503. Ms. Casciola-Rosen is supported by grant R56 AR062615-01A1. Dr. Christopher-Stine’s work was supported by the Huayi and Siuling Zhang Discovery Fund. This research was supported (in part) by the Intramural Research Program of the NIAMS of the NIH. I. Pinal-Fernandez, MD, PhD, Autoimmune Systemic Diseases Unit, Vall d’Hebron University Hospital; L.A. Casciola-Rosen, PhD; L. Christopher-Stine, MD, MPH; A.M. Corse, MD, Johns Hopkins University School of Medicine; A.L. Mammen, NIAMS, NIH. Address correspondence to Dr. A.L. Mammen, Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Expression, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Drive, Room 1146, Building 50, MSC 8024, Bethesda, Maryland 20892, USA. E-mail: andrew.mammen@nih.gov. Accepted for publication April 24, 2015.
Lisa Christopher-Stine
From the Vall d’Hebron University Hospital, Barcelona, Spain; Johns Hopkins University School of Medicine, Baltimore; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), US National Institutes of Health (NIH), Bethesda, Maryland, USA. The Johns Hopkins Rheumatic Disease Research Core Center, where the autoantibody assays were performed, is supported by NIH grant P30-AR-053503. Ms. Casciola-Rosen is supported by grant R56 AR062615-01A1. Dr. Christopher-Stine’s work was supported by the Huayi and Siuling Zhang Discovery Fund. This research was supported (in part) by the Intramural Research Program of the NIAMS of the NIH. I. Pinal-Fernandez, MD, PhD, Autoimmune Systemic Diseases Unit, Vall d’Hebron University Hospital; L.A. Casciola-Rosen, PhD; L. Christopher-Stine, MD, MPH; A.M. Corse, MD, Johns Hopkins University School of Medicine; A.L. Mammen, NIAMS, NIH. Address correspondence to Dr. A.L. Mammen, Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Expression, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Drive, Room 1146, Building 50, MSC 8024, Bethesda, Maryland 20892, USA. E-mail: andrew.mammen@nih.gov. Accepted for publication April 24, 2015.
Andrea M. Corse
From the Vall d’Hebron University Hospital, Barcelona, Spain; Johns Hopkins University School of Medicine, Baltimore; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), US National Institutes of Health (NIH), Bethesda, Maryland, USA. The Johns Hopkins Rheumatic Disease Research Core Center, where the autoantibody assays were performed, is supported by NIH grant P30-AR-053503. Ms. Casciola-Rosen is supported by grant R56 AR062615-01A1. Dr. Christopher-Stine’s work was supported by the Huayi and Siuling Zhang Discovery Fund. This research was supported (in part) by the Intramural Research Program of the NIAMS of the NIH. I. Pinal-Fernandez, MD, PhD, Autoimmune Systemic Diseases Unit, Vall d’Hebron University Hospital; L.A. Casciola-Rosen, PhD; L. Christopher-Stine, MD, MPH; A.M. Corse, MD, Johns Hopkins University School of Medicine; A.L. Mammen, NIAMS, NIH. Address correspondence to Dr. A.L. Mammen, Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Expression, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Drive, Room 1146, Building 50, MSC 8024, Bethesda, Maryland 20892, USA. E-mail: andrew.mammen@nih.gov. Accepted for publication April 24, 2015.
Andrew L. Mammen
From the Vall d’Hebron University Hospital, Barcelona, Spain; Johns Hopkins University School of Medicine, Baltimore; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), US National Institutes of Health (NIH), Bethesda, Maryland, USA. The Johns Hopkins Rheumatic Disease Research Core Center, where the autoantibody assays were performed, is supported by NIH grant P30-AR-053503. Ms. Casciola-Rosen is supported by grant R56 AR062615-01A1. Dr. Christopher-Stine’s work was supported by the Huayi and Siuling Zhang Discovery Fund. This research was supported (in part) by the Intramural Research Program of the NIAMS of the NIH. I. Pinal-Fernandez, MD, PhD, Autoimmune Systemic Diseases Unit, Vall d’Hebron University Hospital; L.A. Casciola-Rosen, PhD; L. Christopher-Stine, MD, MPH; A.M. Corse, MD, Johns Hopkins University School of Medicine; A.L. Mammen, NIAMS, NIH. Address correspondence to Dr. A.L. Mammen, Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Expression, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, 50 South Drive, Room 1146, Building 50, MSC 8024, Bethesda, Maryland 20892, USA. E-mail: andrew.mammen@nih.gov. Accepted for publication April 24, 2015.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis
Iago Pinal-Fernandez, Livia A. Casciola-Rosen, Lisa Christopher-Stine, Andrea M. Corse, Andrew L. Mammen
The Journal of Rheumatology Jul 2015, jrheum.141443; DOI: 10.3899/jrheum.141443
The Prevalence of Individual Histopathologic Features Varies according to Autoantibody Status in Muscle Biopsies from Patients with Dermatomyositis
Iago Pinal-Fernandez, Livia A. Casciola-Rosen, Lisa Christopher-Stine, Andrea M. Corse, Andrew L. Mammen
The Journal of Rheumatology Jul 2015, jrheum.141443; DOI: 10.3899/jrheum.141443